Deltagen, Lexicon Genetics Inc. functional genomics news

The companies settled LEXG's patent infringement litigation against DGEN by entering a licensing and subscription agreement. Under the settlement, DGEN will obtain a commercial license to patents covering LEXG's gene targeting technologies, and LEXG will obtain a subscription to

Read the full 392 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE